Medtech Insights

The global MIVCF treatment device market will be driven by newly approved indications, new product launches, and increasing adoption of advanced premium-priced technologies. As a result, the…

Novel monitoring technologies, changes in CMS reimbursement guidelines, influxes of newly insured patients, and US health demographics will result in a modest expansion of the overall US patient…

The US and European markets for breast implants and reconstructive devices will grow modestly through 2024, driven primarily by expansion of the US market, which accounts for the majority of total…

Moderate expansion of the global breast biopsy device market will be driven primarily by the increasing use of premium-priced VAB devices, as well as growth in procedure volumes resulting from…

The Asia Pacific gynecological device market will continue to expand through 2024 due to greater adoption of treatments for gynecological conditions as well as the adoption of minimally invasive…

The Asia Pacific orthopedic extremity device market will grow at a rapid pace through 2024, primarily as a result of favorable demographics, increasing penetration into existing eligible…

The European market for biopsy devices will be primarily driven by wider implementation of national cancer screening programs, an increase in reimbursement coverage for biopsy procedures,…

The Asia Pacific orthopedic extremity device market will grow at a rapid pace through 2024, primarily as a result of favorable demographics, increasing penetration into existing eligible…

The Asia Pacific gynecological device market will continue to expand through 2024 due to greater adoption of treatments for gynecological conditions as well as continued marketing efforts and…

Continued device approvals in Japan have improved PVD treatment in this country. Growing procedure volumes, especially for lower-limb and aortic indications, have encouraged the development and…

France, Germany, Italy, Spain, UK, Belgium, Netherlands, Sweden, Switzerland, Austria, Czech Republic, Denmark, Finland, Greece, Hungary, Norway, Poland, Portugal, Romania, Russia, Ukraine, RoE

Although innovative premium-priced urological devices will be adopted in Europe over the forecast period, growth in this market will be hindered by cost constraints within the European health care…